GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Total Equity

ME Therapeutics Holding (XCNQ:METX) Total Equity : C$1.36 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Total Equity?

ME Therapeutics Holding's total equity for the quarter that ended in Feb. 2024 was C$1.36 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


ME Therapeutics Holding Total Equity Historical Data

The historical data trend for ME Therapeutics Holding's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Total Equity Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Total Equity
-0.13 0.52

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Total Equity Get a 7-Day Free Trial 0.57 0.52 0.52 0.39 1.36

ME Therapeutics Holding Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

ME Therapeutics Holding's Total Equity for the fiscal year that ended in Aug. 2023 is calculated as

Total Equity=Total Assets(Q: Aug. 2023 )-Total Liabilities(Q: Aug. 2023 )
=0.672-0.148
=0.52

ME Therapeutics Holding's Total Equity for the quarter that ended in Feb. 2024 is calculated as

Total Equity=Total Assets(Q: Feb. 2024 )-Total Liabilities(Q: Feb. 2024 )
=1.364-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ME Therapeutics Holding Total Equity Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines